DK3323811T3 - Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse - Google Patents
Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse Download PDFInfo
- Publication number
- DK3323811T3 DK3323811T3 DK16824515.7T DK16824515T DK3323811T3 DK 3323811 T3 DK3323811 T3 DK 3323811T3 DK 16824515 T DK16824515 T DK 16824515T DK 3323811 T3 DK3323811 T3 DK 3323811T3
- Authority
- DK
- Denmark
- Prior art keywords
- heterocyclic compound
- containing heterocyclic
- nitrogen containing
- preparing
- procedure
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title 4
- 150000002391 heterocyclic compounds Chemical class 0.000 title 2
- 229910052757 nitrogen Inorganic materials 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015141034A JP6412471B2 (ja) | 2015-07-15 | 2015-07-15 | 含窒素複素環化合物の製造方法およびその中間体 |
| PCT/JP2016/070758 WO2017010535A1 (ja) | 2015-07-15 | 2016-07-14 | 含窒素複素環化合物の製造方法およびその中間体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3323811T3 true DK3323811T3 (da) | 2019-07-22 |
Family
ID=57758235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16824515.7T DK3323811T3 (da) | 2015-07-15 | 2016-07-14 | Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10435377B2 (da) |
| EP (1) | EP3323811B1 (da) |
| JP (1) | JP6412471B2 (da) |
| KR (1) | KR102032140B1 (da) |
| CN (1) | CN107848987B (da) |
| AU (1) | AU2016294197B2 (da) |
| BR (1) | BR112018000759A2 (da) |
| CA (1) | CA2992403C (da) |
| DK (1) | DK3323811T3 (da) |
| ES (1) | ES2729958T3 (da) |
| IL (1) | IL256809B (da) |
| MX (1) | MX2018000459A (da) |
| NZ (1) | NZ738953A (da) |
| PL (1) | PL3323811T3 (da) |
| RU (1) | RU2717830C2 (da) |
| SG (1) | SG11201800245QA (da) |
| TR (1) | TR201909774T4 (da) |
| TW (1) | TWI711605B (da) |
| WO (1) | WO2017010535A1 (da) |
| ZA (1) | ZA201800269B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202027749A (zh) | 2018-10-12 | 2020-08-01 | 日商富士軟片股份有限公司 | 急性骨髓性白血病用抗腫瘤劑 |
| EP3875090A4 (en) * | 2018-10-31 | 2021-12-22 | FUJIFILM Corporation | PELLET CONTAINING AN ANTITUMOR AGENT |
| EP3875088A4 (en) * | 2018-10-31 | 2021-12-29 | FUJIFILM Corporation | Package for medical composition containing anti-tumor agent |
| TW202045174A (zh) | 2019-02-28 | 2020-12-16 | 日商富士軟片股份有限公司 | 組合醫藥 |
| MX2024008057A (es) | 2021-12-30 | 2024-08-28 | Biomea Fusion Inc | Compuestos de pirazina como inhibidores de flt3. |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8928839D0 (en) | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Novel compounds |
| ATE407678T1 (de) | 2001-10-17 | 2008-09-15 | Boehringer Ingelheim Pharma | Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung |
| BRPI0610876B8 (pt) | 2005-06-08 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, formulação farmacêutica, e métodos de inibir uma atividade de uma jak cinase, e de inibir uma cascata de transdução de sinal em que jak3 cinase desempenha um papel |
| US20060281755A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators |
| US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| JP5688877B2 (ja) | 2005-11-11 | 2015-03-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌疾患の治療用キナゾリン誘導体 |
| KR101449057B1 (ko) | 2006-03-17 | 2014-10-10 | 암비트 바이오사이언시즈 코포레이션 | 질환 치료용 이미다졸로티아졸 화합물 |
| EP2022785A1 (en) * | 2007-06-20 | 2009-02-11 | Bayer Schering Pharma Aktiengesellschaft | Alkynylpyrimidines as Tie2 kinase inhibitors |
| MX2010007973A (es) | 2008-02-01 | 2010-11-09 | Akinion Pharmaceuticals Ab | Derivados de pirazina y su uso como inhibidores de proteina cinasa. |
| PT2271670E (pt) | 2008-03-14 | 2014-11-28 | Allergan Inc | Ensaio imunobaseado da atividade do serotipo a da toxina botulínica |
| MX353308B (es) | 2008-05-21 | 2018-01-08 | Ariad Pharma Inc | Derivados fosforosos como inhibidores de cinasa. |
| US9908884B2 (en) | 2009-05-05 | 2018-03-06 | Dana-Farber Cancer Institute, Inc. | EGFR inhibitors and methods of treating disorders |
| US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| WO2012061303A1 (en) | 2010-11-01 | 2012-05-10 | Avila Therapeutics, Inc. | Heteroaryl compounds and uses thereof |
| WO2012064706A1 (en) | 2010-11-10 | 2012-05-18 | Avila Therapeutics, Inc. | Mutant-selective egfr inhibitors and uses thereof |
| JP6147727B2 (ja) | 2011-04-01 | 2017-06-14 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | チロシン受容体キナーゼｂｔｋ阻害剤としての置換ｎ−（３−（ピリミジン−４−イル）フェニル）アクリルアミド類似体 |
| RU2616612C2 (ru) | 2011-05-04 | 2017-04-18 | ФОРМА ТиЭм, ЭлЭлСИ | Новые соединения и композиции для ингибирования nampt |
| JP2013157540A (ja) | 2012-01-31 | 2013-08-15 | Toshiba Corp | 半導体装置およびその製造方法 |
| HRP20180037T1 (hr) | 2012-04-17 | 2018-03-23 | Fujifilm Corporation | Heterociklični spoj koji sadrži dušik ili njegovu sol |
| KR101744033B1 (ko) | 2013-10-16 | 2017-06-07 | 후지필름 가부시키가이샤 | 함질소 복소환 화합물의 염 또는 그 결정, 의약 조성물 및 flt3 저해제 |
| KR20150056683A (ko) | 2013-11-15 | 2015-05-27 | (주) 제일피앤티 | 대전 방지 필름 및 이를 이용한 쉴드 백 |
| EP3195866B1 (en) | 2014-08-22 | 2020-11-18 | FUJIFILM Corporation | Pharmaceutical composition for treating flt3 mutation-positive cancer, mutant flt3 inhibitor and uses thereof |
-
2015
- 2015-07-15 JP JP2015141034A patent/JP6412471B2/ja active Active
-
2016
- 2016-07-14 SG SG11201800245QA patent/SG11201800245QA/en unknown
- 2016-07-14 DK DK16824515.7T patent/DK3323811T3/da active
- 2016-07-14 CN CN201680041023.4A patent/CN107848987B/zh not_active Expired - Fee Related
- 2016-07-14 PL PL16824515T patent/PL3323811T3/pl unknown
- 2016-07-14 AU AU2016294197A patent/AU2016294197B2/en not_active Ceased
- 2016-07-14 CA CA2992403A patent/CA2992403C/en active Active
- 2016-07-14 WO PCT/JP2016/070758 patent/WO2017010535A1/ja not_active Ceased
- 2016-07-14 ES ES16824515T patent/ES2729958T3/es active Active
- 2016-07-14 KR KR1020187000990A patent/KR102032140B1/ko not_active Expired - Fee Related
- 2016-07-14 RU RU2018100967A patent/RU2717830C2/ru active
- 2016-07-14 EP EP16824515.7A patent/EP3323811B1/en active Active
- 2016-07-14 TW TW105122147A patent/TWI711605B/zh not_active IP Right Cessation
- 2016-07-14 BR BR112018000759-5A patent/BR112018000759A2/pt active Search and Examination
- 2016-07-14 TR TR2019/09774T patent/TR201909774T4/tr unknown
- 2016-07-14 MX MX2018000459A patent/MX2018000459A/es unknown
- 2016-07-14 NZ NZ738953A patent/NZ738953A/en not_active IP Right Cessation
-
2018
- 2018-01-09 IL IL256809A patent/IL256809B/en active IP Right Grant
- 2018-01-10 US US15/867,122 patent/US10435377B2/en active Active
- 2018-01-15 ZA ZA2018/00269A patent/ZA201800269B/en unknown
-
2019
- 2019-02-11 US US16/272,263 patent/US10562862B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
| DK3555070T3 (da) | Aminsubstituerede, heterocykliske forbindelser som ehmt2-hæmmere og fremgangsmåder til anvendelse deraf | |
| DK3556354T3 (da) | Oral fremstilling af en glucokinaseaktivator og fremgangsmåde til fremstilling deraf | |
| DK3283107T3 (da) | Sammensætninger omfattende en kombination af ipilimumab og nivolumab | |
| DK3317400T3 (da) | Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter | |
| DK3340981T3 (da) | Aryl, heteroaryl og heterocykliske forbindelser til behandling af medicinske forstyrrelser | |
| EP3438109A4 (en) | HETEROCYCLIC CONNECTION | |
| EP3366684A4 (en) | Heterocyclic compound | |
| EP3498693A4 (en) | HETEROCYCLIC CONNECTION | |
| DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
| DK3376859T3 (da) | Mikroorganismer til fremstilling af insektferomoner og relaterede forbindelser | |
| EP3689879A4 (en) | HETEROCYCLIC CONNECTION | |
| DK3277270T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
| DK3519572T5 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
| DK3048295T3 (da) | Fremgangsmåde til opførelse af en vindmølle og vindmølle | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| EP3327019A4 (en) | HETEROCYCLIC CONNECTION | |
| DK3178324T3 (da) | Mikrobicid og fremgangsmåde til fremstilling af samme | |
| DK3484524T3 (da) | Forbindelser og fremgangsmåder til modulation af smn2 | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner | |
| EP3366679A4 (en) | HETEROCYCLIC CONNECTION | |
| EP3444239A4 (en) | Heterocyclic compound | |
| DK3224354T3 (da) | Manipulerede iminreductaser og fremgangsmåder til den reduktive aminering af keton- og aminforbindelser | |
| EP3424905A4 (en) | HETEROCYCLIC CONNECTION |